Correlation Between Kalvista Pharmaceuticals and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and ZyVersa Therapeutics, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and ZyVersa Therapeutics.
Diversification Opportunities for Kalvista Pharmaceuticals and ZyVersa Therapeutics
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Kalvista and ZyVersa is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and ZyVersa Therapeutics
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.32 times more return on investment than ZyVersa Therapeutics. However, Kalvista Pharmaceuticals is 3.15 times less risky than ZyVersa Therapeutics. It trades about 0.06 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 509.00 in Kalvista Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 506.00 from holding Kalvista Pharmaceuticals or generate 99.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kalvista Pharmaceuticals vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Kalvista Pharmaceuticals |
| ZyVersa Therapeutics |
Kalvista Pharmaceuticals and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kalvista Pharmaceuticals and ZyVersa Therapeutics
The main advantage of trading using opposite Kalvista Pharmaceuticals and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | Kalvista Pharmaceuticals vs. Kura Oncology | Kalvista Pharmaceuticals vs. Viridian Therapeutics | Kalvista Pharmaceuticals vs. Replimune Group |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |